iShares Biotechnology ETF (NASDAQ:IBB) Stake Boosted by SYM FINANCIAL Corp

SYM FINANCIAL Corp grew its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 236.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 427 shares of the financial services provider’s stock after purchasing an additional 300 shares during the period. SYM FINANCIAL Corp’s holdings in iShares Biotechnology ETF were worth $58,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of IBB. Column Capital Advisors LLC bought a new stake in iShares Biotechnology ETF in the third quarter valued at $49,000. Premier Path Wealth Partners LLC acquired a new position in iShares Biotechnology ETF during the 4th quarter valued at about $207,000. StrategIQ Financial Group LLC grew its position in iShares Biotechnology ETF by 9.2% in the 4th quarter. StrategIQ Financial Group LLC now owns 5,013 shares of the financial services provider’s stock worth $681,000 after purchasing an additional 422 shares during the last quarter. Brookstone Capital Management increased its stake in shares of iShares Biotechnology ETF by 4.1% in the fourth quarter. Brookstone Capital Management now owns 6,753 shares of the financial services provider’s stock valued at $917,000 after purchasing an additional 269 shares during the period. Finally, Congress Wealth Management LLC DE acquired a new stake in shares of iShares Biotechnology ETF in the third quarter valued at approximately $265,000. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Price Performance

Shares of NASDAQ IBB traded up $2.31 during midday trading on Friday, hitting $132.96. 1,804,184 shares of the company’s stock were exchanged, compared to its average volume of 1,700,513. iShares Biotechnology ETF has a twelve month low of $111.83 and a twelve month high of $141.16. The firm has a market cap of $7.27 billion, a P/E ratio of 17.35 and a beta of 0.86. The stock’s 50 day moving average price is $133.61 and its 200-day moving average price is $130.05.

iShares Biotechnology ETF Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 27th. Shareholders of record on Friday, March 22nd were given a dividend of $0.126 per share. The ex-dividend date of this dividend was Thursday, March 21st. This represents a $0.50 dividend on an annualized basis and a yield of 0.38%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.